Drobo Debuts Gold and Platinum Editions for Power Users
Nov 21, 2017 13:01 pm UTC| Business
SANTA CLARA, Calif., Nov. 21, 2017 -- Today, Drobo announced two new special editions for the 5N2 and the 5D3 to bring performance and peace of mind to power users. Power users among creative professionals, SMBs and...
Nov 21, 2017 13:01 pm UTC| Business
NEW YORK, Nov. 21, 2017 -- Ovid Therapeutics Inc. (NASDAQ:OVID), a biopharmaceutical company committed to developing medicines for patients with rare neurological diseases, today announced that it will present five...
Nov 21, 2017 13:01 pm UTC| Business
NEW YORK, Nov. 21, 2017 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Loews Corporation...
aTyr Pharma to Participate at the Piper Jaffray 29th Annual Healthcare Conference
Nov 21, 2017 13:01 pm UTC| Business
SAN DIEGO, Nov. 21, 2017 -- aTyr Pharma, Inc. (Nasdaq:LIFE), a biotherapeutics company engaged in the discovery and development of immuno-modulatory protein therapeutics to treat patients suffering from rare, severe,...
Nov 21, 2017 13:01 pm UTC| Business
EL SEGUNDO, Calif., Nov. 21, 2017 -- Griffin Capital Company, LLC (“Griffin Capital”) announced today, on behalf of Griffin Capital Essential Asset REIT, Inc. (the “REIT”), the sale of DreamWorks Animation’s...
Nov 21, 2017 13:01 pm UTC| Business
DALLAS, Nov. 21, 2017 -- Dave Buster's Entertainment, Inc., (NASDAQ:PLAY), (“Dave Buster’s” or the “Company”), an owner and operator of entertainment and dining venues, today announced that it will report financial...
Nov 21, 2017 13:01 pm UTC| Business
Doral, FL, Nov. 21, 2017 -- Earth Science Tech, Inc. (OTC PINK: ETST) ("ETST" or "the Company"), an innovative biotech company that operates in the fields of hemp cannabinoid (CBD), nutraceutical, pharmaceutical,...
The “Takaichi Trade”: How Japan’s First Female PM Is Shaping the Yen
How the US–India tariff truce boosts major Indian industries, Surat to Pharma